86 related articles for article (PubMed ID: 32684047)
1. A Dinucleotide Deletion in the
Segev L; Naboishchikov I; Kazanov D; Bernstein E; Shaked M; Arber N; Shapira S
Am Surg; 2020 May; 86(5):480-485. PubMed ID: 32684047
[TBL] [Abstract][Full Text] [Related]
2. Reduced DAXX Expression Is Associated with Reduced CD24 Expression in Colorectal Cancer.
Chen YC; Lee TH; Tzeng SL
Cells; 2019 Oct; 8(10):. PubMed ID: 31614769
[TBL] [Abstract][Full Text] [Related]
3. CD24 single nucleotide polymorphisms and cancer risk.
Yan S; Xu D; Jiang T; Wang P; Yin Y; Wang X; Hua C; Zhang B; Li Z; Lu L; Liu X; Wang B; Zhang D; Zhang R; Sun B; Wang X
Tumour Biol; 2014 Sep; 35(9):8927-32. PubMed ID: 24894672
[TBL] [Abstract][Full Text] [Related]
4. Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer.
Su N; Peng L; Xia B; Zhao Y; Xu A; Wang J; Wang X; Jiang B
Mol Cancer; 2012 Jun; 11():43. PubMed ID: 22731636
[TBL] [Abstract][Full Text] [Related]
5. Combination of targeting CD24 and inhibiting autophagy suppresses the proliferation and enhances the apoptosis of colorectal cancer cells.
Zhuo J; Wang X
Mol Med Rep; 2019 Jul; 20(1):539-548. PubMed ID: 31180548
[TBL] [Abstract][Full Text] [Related]
6. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
7. CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
[TBL] [Abstract][Full Text] [Related]
8. Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas.
Kraus S; Shapira S; Kazanov D; Naumov I; Moshkowitz M; Santo E; Galazan L; Geva R; Shmueli E; Hallack A; Arber N
Dis Markers; 2015; 2015():916098. PubMed ID: 26078485
[TBL] [Abstract][Full Text] [Related]
9. CD24 gene polymorphism--a novel prognostic factor in esophageal cancer.
Sadot E; Kraus S; Stein M; Naboishchikov I; Toledano O; Kazanov D; Arber N; Kashtan H
Int J Biol Markers; 2014 Mar; 29(1):e49-54. PubMed ID: 24474454
[TBL] [Abstract][Full Text] [Related]
10. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
[TBL] [Abstract][Full Text] [Related]
11. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
12. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.
Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566
[TBL] [Abstract][Full Text] [Related]
14. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
[TBL] [Abstract][Full Text] [Related]
15. CD24 knockout prevents colorectal cancer in chemically induced colon carcinogenesis and in APC(Min)/CD24 double knockout transgenic mice.
Naumov I; Zilberberg A; Shapira S; Avivi D; Kazanov D; Rosin-Arbesfeld R; Arber N; Kraus S
Int J Cancer; 2014 Sep; 135(5):1048-59. PubMed ID: 24500912
[TBL] [Abstract][Full Text] [Related]
16. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.
Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462
[TBL] [Abstract][Full Text] [Related]
17. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.
Wang X; Zhang Y; Zhao Y; Liang Y; Xiang C; Zhou H; Zhang H; Zhang Q; Qing H; Jiang B; Xiong H; Peng L
Oncotarget; 2016 Aug; 7(34):55663-55676. PubMed ID: 27494878
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation between vitamin D receptor gene FokI polymorphism and colorectal cancer susceptibility in South-Khorasan of Iran.
Moossavi M; Parsamanesh N; Mohammadoo-Khorasani M; Moosavi M; Tavakkoli T; Fakharian T; Naseri M
J Cell Biochem; 2018 Nov; 119(10):8190-8194. PubMed ID: 29953646
[TBL] [Abstract][Full Text] [Related]
19. Role of MYH polymorphisms in sporadic colorectal cancer in China: a case-control, population-based study.
Yang L; Huang XE; Xu L; Zhou JN; Yu DS; Zhou X; Li DZ; Guan X
Asian Pac J Cancer Prev; 2013; 14(11):6403-9. PubMed ID: 24377541
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting
Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
